Core Viewpoint - The company has successfully completed the re-registration of its health food product, "Shouxiangu Brand Ganoderma Spore Oil Soft Capsules," and received the registration certificate from the National Market Supervision Administration, indicating its compliance with regulatory standards [1] Group 1 - The product has undergone animal testing and has been evaluated to have health benefits that may help enhance immunity [1] - The registration number for the product is Guo Shi Jian Zhu G20200107, and it is valid until August 25, 2030 [1]

Core Viewpoint - The company is launching a shareholder reward activity to express gratitude to shareholders during the Mid-Autumn Festival, aiming to enhance shareholder engagement and understanding of the company's value [1][5]. Group 1: Activity Details - The activity will take place from September 23, 2025, to October 22, 2025, and shareholders who do not participate within this period will forfeit their rights [1]. - Eligible shareholders include those registered with the China Securities Depository and Clearing Corporation as of September 12, 2025, with individual participation limited to natural persons and corporate shareholders allowed to designate up to five representatives [2]. - During the activity, shareholders can purchase specific products at exclusive discounted prices, with a limit of one purchase per person [3]. Group 2: Participation Process - Natural person shareholders can participate by scanning a QR code for the shareholder reward activity, while corporate representatives must complete identity verification through a separate QR code [4]. - The company provides contact information for inquiries regarding the activity, ensuring shareholders can seek assistance if needed [5]. Group 3: Additional Information - The activity is not classified as a profit distribution and participation is voluntary; shareholders who fail to complete necessary procedures will not have claims against the company [6]. - The company retains the final interpretation rights of the activity, emphasizing fairness and transparency [5].

| 证券代码：603896 | 证券简称：寿仙谷 | | 公告编号：2025-062 | | --- | --- | --- | --- | | 债券代码：113660 | 债券简称：寿 22 | 转债 | | 中秋佳节将至，为建立长效、多样的股东回报机制，更借传统节日之韵传递 感恩心意——感谢广大股东长期以来对浙江寿仙谷医药股份有限公司（以下简称 "公司"或"寿仙谷"）的关心与支持，同时让股东在共话中秋、同品佳节意蕴 的氛围中，更好地了解和体验公司产品，深化对公司内在价值的理解与认识，公 司特开展"寿仙谷 2025 年股东回馈"活动。现将活动内容公告如下： 一、活动时间 2025 年 9 月 23 日 00 时至 2025 年 10 月 22 日 12 时。未在该时段参与活动 的，则视为股东自动放弃参与本次活动的权利。 二、参加活动股东范围 截至 2025 年 9 月 12 日（寿仙谷 2025 年第一次临时股东大会股权登记日） 收市后在中国证券登记结算有限责任公司上海分公司登记在册的公司股东，可 以参与本次活动。自然人股东仅限本人参与，法人股东限指定不超过 5 名（含 5 名）自然人代表。 三、活动内容 ...

Core Viewpoint - The company, Zhejiang Shouxiangu Pharmaceutical Co., Ltd., is launching a shareholder reward program in celebration of the Mid-Autumn Festival, aiming to express gratitude to shareholders and enhance their understanding of the company's products and intrinsic value [1]. Group 1: Shareholder Reward Program - The company is conducting the "Shouxiangu 2025 Shareholder Return" activity to establish a long-term and diverse shareholder return mechanism [1]. - During the event, shareholders and their representatives can purchase specific products at exclusive discounted prices, with a limit of one purchase per person [1]. Group 2: Product Offerings - The following products are available for shareholders at discounted prices: - Shouxiangu Xianzhi No. 3 Broken Wall Ganoderma Spore Powder Tablets (去壁款) - Original price: 4752 RMB, Shareholder price: 3299 RMB [2]. - Shouxiangu Xianzhi No. 3 Broken Wall Ganoderma Spore Powder (去壁款) - Original price: 2720 RMB, Shareholder price: 1900 RMB [2]. - Shouxiangu Sugar-Free Iron Skin Maple Bean Granules (2g*10 bags/box) - Original price: 1192 RMB, Shareholder price: 828 RMB [3].

Group 1 - The core idea of the article is that Shouxiangu (603896.SH) is launching a shareholder reward activity in celebration of the Mid-Autumn Festival, aiming to establish a long-term and diverse shareholder return mechanism while expressing gratitude to shareholders for their support [1] - During the event, shareholders and their representatives can purchase specific products at exclusive discounted prices, with a limit of one purchase per person [1] Group 2 - The products available for purchase include: - Shouxiangu Xianzhi No. 3 Broken Wall Ganoderma Spore Powder (去壁款) at a regular price of 4752 yuan, discounted to 3299 yuan for shareholders [2] - Shouxiangu Xianzhi No. 3 Broken Wall Ganoderma Spore Powder (去壁款) at a regular price of 2720 yuan, discounted to 1900 yuan for shareholders [2] - Shouxiangu Sugar-Free Iron Skin Maple Bean Granules (2g*10 bags/box) at a regular price of 1192 yuan, discounted to 828 yuan for shareholders [3]

| 证券代码：603896 | 证券简称：寿仙谷 | | 公告编号：2025-062 | | --- | --- | --- | --- | | 债券代码：113660 | 债券简称：寿 | 22 转债 | | 浙江寿仙谷医药股份有限公司 关于 2025 年股东回馈活动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 中秋佳节将至，为建立长效、多样的股东回报机制，更借传统节日之韵传递 感恩心意——感谢广大股东长期以来对浙江寿仙谷医药股份有限公司（以下简称 "公司"或"寿仙谷"）的关心与支持，同时让股东在共话中秋、同品佳节意蕴 的氛围中，更好地了解和体验公司产品，深化对公司内在价值的理解与认识，公 司特开展"寿仙谷 2025 年股东回馈"活动。现将活动内容公告如下： 一、活动时间 2025 年 9 月 23 日 00 时至 2025 年 10 月 22 日 12 时。未在该时段参与活动 的，则视为股东自动放弃参与本次活动的权利。 二、参加活动股东范围 截至 2025 年 9 月 12 日（寿仙谷 2025 年第一次临时股东 ...

Core Viewpoint - The company announces a shareholder reward event scheduled from September 23 to October 22, 2025, allowing eligible shareholders to purchase products at discounted prices [1] Group 1: Event Details - The shareholder reward event will take place from September 23 to October 22, 2025 [1] - Eligible shareholders can purchase products such as Shouxiangu Xianzhi No. 3 broken-wall Ganoderma lucidum spore powder tablets and sugar-free iron skin maple granules at preferential prices [1] - Individual shareholders must participate by scanning a QR code via WeChat, while corporate shareholders need to submit identification and undergo verification [1] Group 2: Company Policy - The event does not constitute a profit distribution, and the company retains the final interpretation rights regarding the event [1]

Group 1 - The 22nd China International Health Expo opened in Xiamen, focusing on "National Health" and showcasing the achievements of the health industry over the past 30 years [1] - Shouxiangu was awarded the title of "Leading Enterprise in Tribute to 30 Years of Health Industry Development" during the expo [1] - The expo emphasized green development, low-carbon environmental protection, and digital transformation, aiming to build a global health industry communication platform [1] Group 2 - Shouxiangu set up a 100 square meter exhibition hall, integrating brand display, cultural experience, and technological interaction, showcasing its research and industrialization achievements in the field of Ganoderma [2] - The company has established the world's largest Ganoderma genetic resource bank, preserving over 13,000 genetic resources and has developed multiple Ganoderma varieties [2] - Shouxiangu's cultivation base has received organic certification from various regions including China, the EU, the US, Japan, and Canada [2] Group 3 - The company developed the "third-generation wall-breaking technology for Ganoderma spore powder," which reportedly enhances the content of active ingredients and human absorption rates, winning a gold medal at the Geneva International Invention Exhibition [2] - In its digital transformation, Shouxiangu has built a collaborative system across the entire industry chain, including "smart farms, smart factories, smart markets, and smart laboratories" [2] - The cultivation end has implemented an "intelligent adaptive organic cultivation model," increasing the yield of medicinal materials by 50%-80% and improving the stability of active ingredients by 35% [2] Group 4 - At the expo, Shouxiangu displayed three core product series: Ganoderma, Dendrobium, and Saffron, covering traditional Chinese medicine products and health foods [2] - The company also showcased national intangible cultural heritage techniques, including "Wuyi Shouxiangu Traditional Chinese Medicine Processing Skills" and "Tiepi Fengdou" production techniques [2] - Shouxiangu's chairman emphasized the importance of traditional Chinese medicine and the company's commitment to technological innovation and cultural heritage to enhance the Ganoderma industry [2]

Group 1 - The 22nd China International Health Expo opened in Xiamen, focusing on "national health" and showcasing the achievements of the health industry, with Shouxiangu being awarded the title of "Leading Enterprise in Tribute to 30 Years of Health Industry Development" [1] - The expo aims to create a global platform for health industry exchange and cooperation, emphasizing green development, low-carbon environmental protection, and digital transformation [1] - Shouxiangu has established a large germplasm resource bank for Ganoderma lucidum, preserving over 13,000 germplasm resources and has developed multiple varieties [2] Group 2 - The company has developed a third-generation wall-breaking technology for Ganoderma lucidum spore powder, which reportedly enhances the content of effective components and human absorption rates, winning a gold medal at the Geneva International Invention Exhibition [2] - Shouxiangu has led the formulation of various standards for medicinal materials, including multiple international, national, and industry standards, with the ISO standards for Ganoderma lucidum and Dendrobium officinale applied in over 30 countries and regions [2] - The company is advancing the construction of a "smart farm + smart factory + smart market + smart laboratory" system, incorporating intelligent management in planting and processing, with some bases recognized as national-level 5G factories [2] Group 3 - The company continues to focus on research and innovation across the entire Ganoderma lucidum industry chain, aiming to promote product and technology upgrades [3]

Core Viewpoint - The 22nd China International Health Expo highlighted the achievements of Zhejiang Shouxiangu Pharmaceutical Co., Ltd., recognized as a leading enterprise in the health industry, showcasing its innovations in the Ganoderma lucidum sector and its commitment to traditional Chinese medicine and technological advancement [2][5]. Group 1: Company Achievements - Shouxiangu has established the world's largest Ganoderma lucidum germplasm resource bank, preserving over 13,388 varieties since the 1990s [3]. - The company developed the first domestically approved Ganoderma lucidum variety "XianZhi No. 1" in 2001, breaking the reliance on imports from Japan and South Korea [3]. - Shouxiangu has built over 10,000 acres of organic medicinal herb cultivation bases, achieving various organic certifications from China, the EU, the US, Japan, and Canada [3]. Group 2: Technological Innovations - The company has independently developed the third-generation wall-breaking technology for Ganoderma lucidum spore powder, significantly enhancing the effective ingredient content by over 10 times and improving absorption rates by an average of 29 times compared to regular wall-breaking spore powder [3]. - Shouxiangu has been recognized with a gold medal at the 46th Geneva International Exhibition of Inventions for its technological breakthroughs [3]. Group 3: Standardization and Digital Transformation - Since 2006, Shouxiangu has undertaken the development of over 100 international, national, and industry standards, including ISO standards for Ganoderma lucidum and other medicinal herbs [4]. - The company is set to implement new ISO standards for "White Atractylodes" and "Wall-Breaking Ganoderma lucidum spore powder" in July 2024 and July 2025, respectively, enhancing China's international influence in traditional medicine [4]. - Shouxiangu is advancing digital transformation by creating a collaborative application system across the entire industry chain, including smart farms and factories, which has led to a 50%-80% increase in medicinal herb yield and a 35% improvement in effective ingredient stability [4]. Group 4: Product Offerings and Cultural Heritage - At the expo, Shouxiangu showcased its core product lines, including Ganoderma lucidum, Dendrobium, and saffron, covering traditional Chinese medicine products, health foods, and herbal daily necessities [5]. - The company also presented its national intangible cultural heritage techniques for traditional Chinese medicine processing, emphasizing its commitment to cultural preservation alongside technological innovation [5].